The Chicago Entrepreneur

[stock-market-ticker symbols="AAPL;MSFT;GOOG;HPQ;^SPX;^DJI;LSE:BAG" stockExchange="NYSENasdaq" width="100%" palette="financial-light"]
Menu
Earnings

Pfizer expects 2023 sales to decline as much as 33% compared with record-breaking 2022

The pharmaceutical company booked $100.3 billion for full-year 2022, an all-time high.

Previous post Meta shares soar 17% on fourth-quarter revenue beat
Next post UPS revenue falls short of expectations despite growth in U.S. business

More Stories